MMCAP International’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-350,000
Closed -$3.7M 317
2026
Q1
$3.7M Hold
350,000
0.32% 79
2025
Q4
$3.67M Hold
350,000
0.37% 66
2025
Q3
$3.62M Buy
+350,000
New +$3.61M 0.42% 54

Other funds holding TDAC

MMCAP International's TDAC Position: Q2 2026 in Review

MMCAP International sold out of Translational Development Acquisition Corp (TDAC) in Q2 2026, closing a stake of 350,000 shares — an estimated $3.7M sold.

MMCAP International first reported a position in TDAC in Q3 2025 and held it in 3 quarters. The position peaked at $3.7M in Q1 2026. 35 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

  • MMCAP International reported no remaining Translational Development Acquisition Corp position as of Q2 2026 after selling out during the quarter.
  • MMCAP International sold 350,000 Translational Development Acquisition Corp shares in Q2 2026, an estimated $3.7M.
  • MMCAP International first reported a position in Translational Development Acquisition Corp in Q3 2025 and held it in 3 quarters.
  • MMCAP International's Translational Development Acquisition Corp position peaked at $3.7M in Q1 2026.
  • 35 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on MMCAP International's 13F filing for Q2 2026, filed 14 Aug 2026.